Safety of lysosubtilin per os in mice, rabbits and calves

Veterinary Research

Volumn 28, Issue 4, 1997, Pages 385-395

  Biziulevichius, G A ^a   Arestov, I G ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b Vitebsk State Academy of Veterinary Medicine   (Belarus)

Author keywords

Lysosubtilin; Mouse; Newborn calf; Rabbit; Safety

Indexed keywords

SUBTILIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CATTLE; CONTROLLED STUDY; DRUG SAFETY; ENZYME DEGRADATION; GASTROINTESTINAL DISEASE; NONHUMAN; PROPHYLAXIS; RABBIT; TOXICITY TESTING;

ANIMALIA; BACILLUS SUBTILIS; BOS TAURUS; ORYCTOLAGUS CUNICULUS;

EID: 0030753277     PISSN: 09284249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Abramov SS, Shevehenko IS (1991) Enzyme preparations in prophylaxis and complex therapy of calves for diarrhoea. Veterinariya (Mosc) 9, 49-51 (in Russian, with English abstract)
2. Anonymous (1985) Methodical recommendations for experimental study of new enzyme preparations intended for clinical trials. USSR Ministry of Health Care, Moscow, Russia, (in Russian)
3. Anonymous (1986) Rules on veterinary examination of slaughter animals and veterinary-sanitary examination of meat and its products. USSR Ministry of Agriculture, Moscow, Russia, (in Russian)
4. Anonymous (1991) Guidelines for the safety pharmacology study required for application for approval of manufacturing (import) of new drugs. Director of New Drug Division, Pharmaceutical Affairs Bureau. Japanese Ministry of Health and Welfare, Japan
5. Araneo BA, Cebra JJ, Beuth J, Fuller R, Heidt PJ, Midvedt T, Nord CE, Nieuwenhuis P, Manson WL, Pulverer G, Rusch VC, Tanaka R, Van Der Waaij D, Walker PJ, Wells CL (1996) Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies: an overview of current literature. Zentralbl Bakteriol 283, 431-465
6. Bätza HJ (1995) Perspektiven der rechtlichen Regelung für die Sicherung der Tiergesundheit in Ländern der Europäischen Union. Dtsch Tieraerztl Wochenschr 102, 288-293
7. Belyakov IM (1975) Diagnostics of internal noninfectious diseases in livestock. Kolos, Moscow, Russia, (in Russian)
8. Biziulevichius GAS, Kislukhina OV (1988) Lytic enzymes in veterinary medicine. A review. Veterinariya (Mosc) 3, 56-59 (in Russian)
9. Biziulevichius GA, Arestov IG (1997) In vivo studies on lysosubtilin. 1. Efficacy for prophylaxis and treatment of gastrointestinal disorders in newborn calves. Vet Res 28, 19-35
10. Biziulevichius GAS, Shablinskas AJ, Zhukaite VP, Kislukhina OV (1987) Lysosubtilin G 10X, a new antimicrobial agent for treatment and prophylaxis. Physicochemical properties. Antibiot med biotekhnol/Antibiot med biotechnol 32, 331-333 (in Russian, with English abstract)
11. Biziulevichius GAS, Shablinskas AJ, Zhukaite VP, Kislukhina OV (1989) Antibacterial spectrum of lysosubtilin G10X Antibiot khimioter/Antibiot chemother (Mosc) 34, 579-581 (in Russian, with English abstract)
12. Biziulevichius GA, Zhukaite W, Kislukhina O (1995) Lysosubtilin - a broad-spectrum action preparation of lytic enzymes for veterinary use: in vitro studies on activators and inhibitors, complex structure and antifungal action. Biomed Lett 52, 43-57
13. Blackburn P, Pollack J (1990) Method of treating mastitis and other staphylococcal infections. European Patent 359873
14. Dooley JF (1979) The role of clinical chemistry in chemical and drug safety evaluation fay use of laboratory animals. Clin Chem 25, 345-347
15. Fraser CM (Ed) (1991) The Merck veterinary manual. A handbook of diagnosis, therapy, and disease prevention and control for the veterinian, 7th ed. Merck and Co Inc, Rahway, New Jersey, USA, 965-970
16. Ghuysen JM, Tipper DJ, Strominger JL (1966) Enzymes that degrade bacterial cell walls. Methods Enzymol 8, 685-699
17. Kedrova EM (1962) Determination of sulfhydryl groups by way of amperometric titration. Methodological Letter. Institute of Biological and Medical Chemistry of Academy of Medical Sciences of USSR, Moscow, Russia (in Russian)
18. Kinter LB, Gossett KA, Kerns WD (1994) Status of safety pharmacology in the pharmaceutical industry, 1993, Drug Dev Res 32, 208-216
19. Kislukhina OV (1976) Determination of lytic activity of lysosubtilin by action towards Escherichia coli cells. Mikrobiologischeskaya promyschlennostj/ Microbiological industry, 141, 43-45 (in Russian)
20. Kislukhina OV, Kalunyants KA, Alenova DZh (1990) Enzymatic lysis of micoorganisms. Rauan, AlmaAta, Kazakhstan, 191-193 (in Russian)
21. Litchfield ST. Wilcoxon FJ (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96, 99-113
22. Matusevich VF, Bityukov VA, Vysokos NP, Dmitriev AF, Nagornaya TS (1971) Ways of determining natural resistance of livestock. Trudy Tselinogradskogo Skh Inst/Proc Tselirtogradsk Inst Agriculture 8, 8-19 (in Russian)
23. Murphy DJ, Gossett KA, Kerns WD (1995) Clinical and regulatory perspectives on general/safety pharmacology tests. Results of pharmaceutical industry survey. Drug Dev Res 35, 150-157
24. Pariza MW, Foster EM (1983) Determining the safety of enzymes used in food processing. J Food Prot 46, 453-468
25. Pearson EG, Dirksen G, Meyer J, Setz A, Rowe KE (1995) Evaluation of liver function tests in neonatal calves. J Am Vet Med Assoc 207, 1466-1469
26. Phaff HJ (1977) Enzymatic yeast cell wall degradation. Adv Chem Ser 160, 244-282
27. Piddock LJV (1996) Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic - resistant bacteria that infect man and compromise antimicrobial chemotherapy ? J Antimicrob Chemother 38, 1-3
28. Prater DA, Bertone JJ, Letonja T, Vaughn SD (1996) Clinical investigation of new animal drugs by vet erinary practitioners. J Am Vet Med Assoc 208, 190-194
29. Proctor VA, Cunningham FE (1988) The chemistry of lysozyme and its use as a food preservative and a pharmaceutical. Crit Rev Food Sci Nutr 26, 359-395
30. Rokitskii PF (1973) Biological Statistics. Vysheisha shkola, Minsk, Byelarus (in Russian)
31. Severin A, Tomasz A (1995) Selective lysis of cultures and cell walls of penicillin-resistant but not penicillin-susceptible Streptococcus pneumoniae strains by a murein hydrolase complex J Bacterial 177, 3316-3319
32. Sirvydis V, Pietaris K, Gruzhauskas R, Pietariene L (1989) Toxicity studies of enzyme preparation lysozyme G3X. LVA darbai. Veterinariya/Proc Lithuanian Acad Vet Med. Vet Med 19, 102-105 (in Lithuanian, with Russian abstract)
33. Skryabin GK, Kulaev IS (1990) Lysoamidase - a challenge to microbes. Nauka v SSSR/Science in the USSR 2, 52-53 (in Russian)
34. Smirnov AM, Konopeljko PYa, Postnikov VS, Belyakov IM, Dugin GL, Pushkarev RP, Kondratjev VS, Urazaev NA (1981) Clinical diagnostics of internal noninfectious diseases in livestock. Kolos, Leningrad, Russia (in Russian)
35. Strominger JL, Ghuysen JM (1967) Mechanisms of enzymatic bacteriolysis. Science 156, 213-221
36. Valionis M, Musteikis B (1980) Schemes of treating calves with dyspepsia. Informative Publication. Lithuanian Ministry of Agriculture, Vilnius (in Lithuanian, with Russian abstract)
37. Weingand K, Bloom J, Carakostas M, Hall R, Helfrich M, Latimer K, Levine B, Neptun D, Rebar A, Stitzel K, Troup C (1992) Clinical pathology testing recommendations for nonclinical toxicity and safety studies. Toxicol Pathol 20, 539-543
38. Weingand K, Brown G, Hall R, Davies D, Gossett K, Neptun D, Waner T, Matsuzava T, Salemink P, Froelke W, Provost JP, Dal Negro G, Batchelor J, Nomura M, Groetsch H, Boink A, Kimball J, Woodman D, York M, Fabiabson-Johnson E, Lupart M, Melloni E (1996) Harmonization of animal clinical pathology testing in toxicity and safety studies. Fundam Appl Toxicol 29, 198-201
39. Zakharova IYa, Pavlova IN (1985) Lytic enzymes of microorganisms. Naukova Dumka, Kiev, Ukraine (in Russian)
40. Znaidauskas B, Marushka R, Malakauskas V, Aniulis E, Laurusevichius S (1989) Toxicity assessment of enzyme preparation lysosubtilin G10X. LVA darbai. Veterinariya/Proc Lithuanian Acad Vet Med Vet Med 19, 184-187 (in Lithuanian, with Russian abstract)
41. Zygmunt WA, Tavormina PA (1972) Lysostaphin: model for a specific enzymatic approach to infectious disease. Prog Drug Res 16, 309-333